Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands

June 8, 2011 By Bio-Medicine.Org

NEW YORK, June 8, 2011 /PRNewswire/ — According to a report
published today by Thomson CompuMark, part of Thomson Reuters, the
pharmaceutical industry has begun to adapt to stricter governmental
brand name standards globally by rapidly increasing the number of
trademarks it files for every new drug. These newer standards by
the U.S. Food and Drug Administration (FDA) and European Medicines
Agency (EMA) are part of an effort to prevent
look-alike/sound-alike pharmaceutical brand names and have led to
increased rejection rates of new drug names.

The special report, Pharmaceutical Trademarks: How to Survive
the Name Game – New Challenges and Opportunities for
Pharmaceutical Companies
, tracks trends in pharmaceutical
trademark activity over the last 30 years, incorporates input from
leading trademark attorneys and pharmaceutical industry executives
and analyzes trademark initiatives at the FDA and EMA to shed light
on this critical issue. Following are some of the key observations
in the analysis:

  • FDA and EMA Rejection Rates Up: The long-term FDA
    trademark rejection rate is 30%, but it has increased to
    approximately 36% in recent years as the organization has adopted a
    more stringent approach to brand approvals. Combined, the FDA and
    EMA are rejecting 40%-50% of pharmaceutical trademarks each
    year.
  • More than 300% Increase in Global Pharma Trademark
    Filings
    : Between 1980 and 2010, the number of pharmaceutical
    trademarks filed increased by more than 300%. A total of 238,010
    pharmaceutical trademarks were filed globally in 2010.
  • China Filing Most Pharmaceutical Trademarks in 2010:
    Chinese firms filed 36,105 pharmaceutical trademarks in 2010, more
    than any other region globally. China was followed by the US
    (27,545) and India (26,123). Some surprise emerging markets such as
    Vietnam, V

    ‘/>”/>

SOURCE

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech